Literature DB >> 10508012

Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.

E J Ernst1, S Hashimoto, J Guglielmo, T Sawa, J F Pittet, H Kropp, J J Jackson, J P Wiener-Kronish.   

Abstract

The effect of antibiotics on the acute lung injury induced by virulent Pseudomonas aeruginosa PA103 was quantitatively analyzed in a rat model. Lung injury was induced by the instillation of PA103 directly into the right lower lobes of the lungs of anesthetized rats. The alveolar epithelial injury, extravascular lung water, and total plasma equivalents were measured as separate, independent parameters of acute lung injury. Four hours after the instillation of PA103, all the parameters were increased linearly depending on the dose of P. aeruginosa. Next, we examined the effects of intravenously administered antibiotics on the parameters of acute lung injury in D-galactosamine-sensitized rats. One hour after the rats received 10(7) CFU of PA103, an intravenous bolus injection of aztreonam (60 mg/kg) or imipenem-cilastatin (30 mg/kg) was administered. Despite an MIC indicating resistance, imipenem-cilastatin improved all the measurements of lung injury; in contrast, aztreonam, which had an MIC indicating sensitivity, did not improve any of the lung injury parameters. The antibiotics did not generate different quantities of plasma endotoxin; therefore, endotoxin did not appear to explain the differences in lung injury. This in vivo model is useful to quantitatively compare the efficacies of parenteral antibiotic administration on Pseudomonas airspace infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508012      PMCID: PMC89488          DOI: 10.1128/AAC.43.10.2389

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Aztreonam in infections due to aerobic gram-negative bacteria.

Authors:  K D Allen; H T Green
Journal:  J Antimicrob Chemother       Date:  1989-02       Impact factor: 5.790

Review 2.  Imipenem: first of a new class of beta-lactam antibiotics.

Authors:  M Barza
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

3.  Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury.

Authors:  S Hashimoto; E Wolfe; B Guglielmo; R Shanks; J Sundelof; J F Pittet; E Thomas; J Wiener-Kronish
Journal:  J Antimicrob Chemother       Date:  1996-11       Impact factor: 5.790

4.  Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; R P Barton; K A Mogan
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

5.  Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.

Authors:  W Cullman; K H Büscher; W Dick
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

6.  Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.

Authors:  T Sawa; K Kurahashi; M Ohara; M A Gropper; V Doshi; J W Larrick; J P Wiener-Kronish
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

7.  Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis.

Authors:  B Strandvik; A S Malmborg; T Bergan; H Michalsen; O T Storrøsten; B Wretlind
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

Review 8.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

9.  Disposition of [14C]aztreonam in rats, dogs, and monkeys.

Authors:  K J Kripalani; S M Singhvi; S H Weinstein; D W Everett; M S Bathala; A V Dean; C E Ita; L Lawrence; F S Meeker; J M Shaw
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

10.  Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.

Authors:  J Birnbaum; F M Kahan; H Kropp; J S MacDonald
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

View more
  7 in total

1.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  V-antigen genotype and phenotype analyses of clinical isolates of Pseudomonas aeruginosa.

Authors:  Leonard R Allmond; Temitayo Ajayi; Kiyoshi Moriyama; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

3.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.

Authors:  Teiji Sawa; Emi Ito; Vinh Huu Nguyen; Matthew Haight
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Mechanical ventilation and lung infection in the genesis of air-space enlargement.

Authors:  Alfonso Sartorius; Qin Lu; Silvia Vieira; Marc Tonnellier; Gilles Lenaour; Ivan Goldstein; Jean-Jacques Rouby
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 5.  Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxia-inducible factor-1alpha.

Authors:  John J Haddad
Journal:  Crit Care       Date:  2002-10-14       Impact factor: 9.097

6.  Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Authors:  Laurent Robriquet; François Collet; Antoine Tournoys; Thierry Prangère; Rémi Nevière; François Fourrier; Benoît P Guery
Journal:  Respir Res       Date:  2006-03-22

7.  Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model.

Authors:  Karine Faure; Junichi Fujimoto; David W Shimabukuro; Temitayo Ajayi; Nobuaki Shime; Kiyoshi Moriyama; Edward G Spack; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Immune Based Ther Vaccines       Date:  2003-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.